Search results - 9 results
Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.
deficiencies, SF ivermectin samples, intercepted in large quantities by the Belgian regulatory agencies during the period 2021-2022, were analyzed in our official medicines control laboratory. None of the samples ...
Microbial quality analysis of falsified medicines seized by controling agencies
Publication Type: Dissertation Authors: Debehault, Loïc; Vanhee, Celine Source: La Haute école en Hainaut, Mons, Mons, p.80 (2023) Abstract: The global trade in illicit pharmaceuticals persists as a profitable criminal enterprise, despite the concerted ef ...
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection
Official Medicines Control Laboratory Network (GEON), on tadalafil. A classical market surveillance study, evaluating compliance to the European Pharmacopoeia, was combined with a fingerprint study, the ...
Contents of Amoxicillin Drugs Dispensed in Goma, Democratic Republic of Congo
9 combined specimens. Our results highlight the need for drug quality control through inspection and specific analytical methods such as spectrophotometry and chromatography to reduce the public health ...
GEONs API fingerprint project: Selection of analytical techniques for clustering of sildenafil citrate API samples
Abstract: Through its Active Pharmaceutical Ingredient Working Group (API- WG) the General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for ...
European fingerprint study on omeprazole drug substances using a multi analytical approach and chemometrics as a tool for the discrimination of manufacturing sources
substances and prevent the use of non-compliant API s, Official Medicine Control Laboratories work together in a European network developing coordinated strategies and programmes. The API working group ...
The occurrence of non-anatomical therapeutic chemical-international nonproprietary name molecules in suspected illegal or illegally traded health products in Europe: A retrospective and prospective study.
The General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), regularly organises ...
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.
that controlling laboratories need to anticipate the uprising of these types of potentially dangerous molecules and must therefore be able to correctly identify these compounds. Therefore, these findings ...
API Testing: how OMCLs can support the control of APIs
Publication Type: Scientific poster, presentation or proceeding Authors: Eric Deconinck; Yvan Grange Source: EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow’s Medicines, EDQM, Strasbourg, France (2019) Health Topics: Médicaments il ...